About
Driven interdisciplinary biotech executive focused on developing transformational medicines for patients in need. Leverages critical thinking, creative and collaborative problem-solving, and culture-focused communication and coaching to lead development and implementation of cross-functional portfolio and program strategy.20+ years in early-stage medicines development across a range of therapeutic modalities, roles, and companies. Experience with small molecules and cell therapy, primarily but not exclusively focused in oncology, across small startups, mid-sized biotech, and global CRO. Most recently led the development of the emerging oncology pipeline of ex vivo autologous cell therapies at bluebird bio, transitioning to the 2seventy bio spinout.
Work
Founder & Leadership at Bicycle Therapeutics